GlassScriptPhysician profile
Jordan Gales
NPI 1285166702
$38,557.57
in general payments reported to CMS, 2019-2025
39 companies · $5,697 in 2025
The $5,697 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $519 · 2021: $2,532 · 2022: $6,028 · 2023: $12K · 2024: $11K · 2025: $5,697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $13K · Grant: $2,000 · Education: $551 · Entertainment: $17.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,506.11 |
| Travel and Lodging | $13,403.48 |
| Grant | $2,000.00 |
| Education | $551.46 |
| Entertainment | $17.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,585.36 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Na |
| Abbott Laboratories | $10,970.45 | 2021-2025 | Ensite Precision, Ensite, Gallant |
| Boston Scientific Corporation | $3,975.94 | 2021-2025 | Farapulse, Emblem Mri S-Icd, General - Therapies |
| Biosense Webster, INC. | $3,244.51 | 2022-2025 | Carto 3, Nuvision Ice Catheter |
| Philips North America LLC | $920.45 | 2024-2025 | (9520) Igt Devices Undivided, (9124) Lm Undivided, Igt Devices Undivided |
| Inari Medical, INC. | $801.14 | 2021-2022 | |
| Abiomed | $764.22 | 2020-2022 | |
| Medical Device Business Services, INC. | $743.90 | 2024 | Carto 3 |
| Actelion Pharmaceuticals US, INC. | $714.15 | 2020-2024 | Opsumit, Uptravi |
| Impulse Dynamics (USA) INC. | $625.20 | 2022-2025 | Optimizer, Optimizer |
| Astellas Pharma US INC | $523.15 | 2020-2021 | |
| Pfizer INC. | $465.78 | 2020-2024 | |
| Amgen INC. | $465.39 | 2021-2025 | Repatha |
| Cardiovascular Systems INC. | $379.05 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $257.32 | 2022-2024 | Lifevest |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Gales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.